Increased CSF levels of nerve growth factor in patients with Alzheimer's disease

Neurology

Volumn 54, Issue 10, 2000, Pages 2009-2011

  Hock, Christoph ^b   Heese, K ^a   Muller Spahn F ^c   Huber, P ^c   Riesen, W ^c   Nitsch, R M ^c   Otten, U ^c  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c NONE

Author keywords

Basal forebrain; Dementia; ELISA; Neurotrophins

Indexed keywords

NERVE GROWTH FACTOR;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BIOACCUMULATION; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL;

EID: 0034705173     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.54.10.2009     Document Type: Article

References (10)

1. Mufson EJ, Kroin JS, Sendera TJ, Sobreviela T. Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative diseases. Prog Neurobiol 1999;57:451-484.
2. Cummings JL, Vinters HV, Cole GM, Khachaturian ZS. Alzheimer's disease: etiologies, pathophysiology, cognitive reserve, and treatment opportunities. Neurology 1998;51(suppl 1):S2-S17.
3. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
4. Weskamp G, Otten U. An enzyme-linked immunoassay for nerve growth factor: a tool for studying regulatory mechanisms involved in NGF production in brain and peripheral tissues. J Neurochem 1987;48:1779-1786.
5. McDowell IF, Wisdom GB, Trimble ER. Apolipoprotein E phenotype determined by agarose gel electrofocusing and immunoblotting. Clin Chem 1989;35:2070-2073.
6. Hansen PS, Gerdes LU, Klausen IC, Gregersen N, Faergeman O. Genotyping compared with protein phenotyping of the common apolipoprotein E polymorphism. Clin Chim Acta 1994; 224:131-137.
7. Scott SA, Mufson EJ, Weingartner JA, Skau KA, Crutcher KA. Nerve growth factor in Alzheimer's disease: increased levels throughout the brain coupled with declines in nucleus basalis. J Neurosci 1995;15:6213-6221.
8. Murase K, Nabeshima T, Robitaille Y, et al. NGF level is not decreased in the serum, brain spinal fluid, hippocampus, or parietal cortex of individuals with Alzheimer's disease. Biochem Biophys Res Commun 1993;193:198-203.
9. Suzaki I, Kara T, Tanaka C, Dejima S, Takeshita K. Elevated nerve growth factor levels in cerebrospinal fluid associated with progressive cortical atrophy. Neuropediatrics 1997;28: 268-271.
10. Bracci-Laudiero L, Aloe L, Levi-Montalcini R, et al. Multiple sclerosis patients express increased levels of β-nerve growth factor in cerebrospinal fluid. Neurosci Lett 1992;147:9-12.